Skip to content
November 1, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Survivorship and Post-Treatment
  • A Legacy of Compassion: How Sharsheret Transformed Cancer Support for Jewish Families
  • Survivorship and Post-Treatment

A Legacy of Compassion: How Sharsheret Transformed Cancer Support for Jewish Families

Rifan Muazin May 19, 2026 6 minutes read
0
a-legacy-of-compassion-how-sharsheret-transformed-cancer-support-for-jewish-families

By Editorial Staff
December 01, 2025

In the landscape of modern patient advocacy, few organizations have managed to bridge the gap between clinical necessity and emotional survival as effectively as Sharsheret. As the organization marks a poignant milestone—the 10th anniversary of the passing of its founder, Rochelle Shoretz—the organization’s mission remains as vital as it was at its inception. Today, Sharsheret serves as a global beacon for those navigating the complexities of breast and ovarian cancer, particularly within the Jewish community.

This year-end, the founders’ sons, Shlomo and Dovid Mirsky, are issuing a clarion call to the public to ensure that the lifeline their mother envisioned continues to reach the thousands of families who rely on it every year.


The Genesis: A Dining Room Table Movement

The story of Sharsheret began not in a boardroom, but in the intimate setting of a family home. In 2001, when breast cancer was still frequently discussed in hushed tones or veiled in stigma, Rochelle Shoretz was diagnosed. At the time, her sons Shlomo and Dovid were just three and five years old.

Shoretz, a woman of profound intellect and drive, faced the daunting task of reconciling her cancer treatment with the demands of motherhood, professional life, and her commitment to Jewish traditions. She found the medical system cold and the emotional support landscape barren. The turning point came when she met Lauryn Weiser, another young Jewish mother navigating the same harrowing path.

This singular connection revealed a systemic void: there was no structured platform for patients to share the unique cultural, religious, and parenting challenges associated with cancer. Shoretz transformed her personal struggle into a public mission, establishing Sharsheret—which translates to "chain" in Hebrew—to ensure that no woman would ever have to face that journey alone.


A Chronology of Impact: From Local Support to Global Advocacy

The evolution of Sharsheret is a testament to the power of grassroots initiative scaling into a sophisticated international organization.

  • 2001: Sharsheret is founded by Rochelle Shoretz, starting as a small group of five women meeting around her dining room table to share resources and emotional support.
  • 2000s: The organization introduces the "Busy Box" initiative, a signature program designed to support the children of cancer patients. By providing age-appropriate activities, the program helps families maintain a semblance of normalcy during the intense, exhausting cycles of chemotherapy and surgery.
  • 2015: The organization suffers a profound loss with the passing of Rochelle Shoretz. Despite her absence, the infrastructure she built proves resilient, transitioning into a multi-faceted support network.
  • 2015–2025: Sharsheret expands its reach, moving beyond peer-to-peer support to include genetic counseling, financial assistance programs, and partnerships with major oncology centers worldwide.
  • 2025: Sharsheret marks 10 years since the passing of its founder, now supporting more than 275,000 individuals annually, effectively becoming the gold standard for culturally sensitive cancer support.

Supporting Data: The Scale of the Need

The growth of Sharsheret is not merely a narrative of charity, but one of medical and sociological necessity. Cancer statistics, particularly regarding breast and ovarian cancer, highlight a specific need for the type of tailored support Sharsheret provides.

The Role of Genetic Predisposition

Within the Ashkenazi Jewish population, there is a statistically higher prevalence of BRCA1 and BRCA2 gene mutations, which significantly increase the lifetime risk of developing breast and ovarian cancers. Sharsheret has become a primary educator in this space, helping families navigate the high-stress decisions regarding genetic testing and prophylactic treatments.

Measuring the Impact

Current data illustrates the sheer volume of the organization’s reach:

Help Us Carry Forward Our Mother’s Legacy: Support Sharsheret This Year-End
  • Annual Reach: Over 275,000 people are impacted by Sharsheret’s resources each year.
  • Patient Advocacy: Sharsheret acts as a primary liaison between patients and the medical community, helping to translate complex medical jargon into actionable lifestyle and treatment plans.
  • Mental Health Integration: Through its support groups and one-on-one counseling, the organization reduces the psychological burden of diagnosis, which has been clinically linked to improved patient compliance with treatment protocols.

The Human Element: The Mirsky Perspective

For Shlomo and Dovid Mirsky, the organization is more than a non-profit; it is a living memorial to their mother. Their personal testimony offers a rare glimpse into the "Busy Box" program, which provided them with comfort during their mother’s treatments.

"We were only 3 and 5 at the time," Shlomo Mirsky notes. "The Busy Box wasn’t just a toy; it was a buffer between our childhood and the harsh reality of hospital visits. That is the essence of what Sharsheret does—it protects the family unit even when the physical health of the mother is compromised."

The brothers emphasize that while the organization has grown into an international movement, its core mission remains the same as it was in 2001: one-on-one connection. "Mom realized that you can have the best doctors in the world, but if you don’t have someone who understands the specific cultural and emotional language of your life, you are still essentially alone," Dovid adds.


Official Response and Institutional Implications

Medical professionals and oncologists frequently cite Sharsheret as a vital component of the "whole-patient" care model.

"The medical community provides the science," says one oncology department head familiar with the organization. "But Sharsheret provides the humanity. They bridge the gap between clinical appointments, addressing the ‘what happens when I go home’ questions that doctors often lack the time to fully explore."

Implications for the Future

As Sharsheret enters its next decade, the organization is focusing on:

  1. Digital Scalability: Leveraging AI and advanced telehealth platforms to ensure that even those in remote locations have access to peer support.
  2. Increased Genetic Literacy: Working with medical institutions to ensure that Jewish women are aware of the risks and the resources available for early detection.
  3. Endowment for Continuity: The current year-end campaign is not just for operational costs; it is designed to build a sustainable endowment, ensuring that the next generation of children—like Shlomo and Dovid—have access to the same resources their predecessors did.

Call to Action: Ensuring the Legacy

The year-end period is a critical juncture for non-profit organizations, and for Sharsheret, the 2025 campaign carries extra weight. With the 10th anniversary of Shoretz’s passing, the organization is calling on the community to honor her memory through active contribution.

"We know that thanks to your generosity, Mom is looking down with pride," the Mirsky brothers wrote in their appeal. "We are not just asking for donations; we are asking you to join us in building a healthier, brighter future for the next generation of Jewish women and their families."

To support this mission and contribute to the ongoing legacy of Rochelle Shoretz, donations can be made through the official portal at link.Sharsheret.org/EOY.

In a world that often feels divided, the "chain" that Shoretz forged in 2001 remains unbroken, serving as a testament to the fact that when one person decides to turn their pain into a purpose, the ripple effects can change the world for hundreds of thousands. As the holiday season approaches, the focus remains on the light of hope that Sharsheret brings into the lives of families across the globe.

About the Author

Rifan Muazin

Administrator

View All Posts

Post navigation

Previous: From Discovery to Decision: Navigating the Complex Realities of Genetic Cancer Predisposition
Next: Engineering Biology: Cellular Intelligence Acquires Novo Nordisk’s Landmark Parkinson’s Therapy

Related Stories

the-intersection-of-glp-1-medications-and-breast-cancer-navigating-emerging-science-4
  • Survivorship and Post-Treatment

The Intersection of GLP-1 Medications and Breast Cancer: Navigating Emerging Science

Dwi Wanna October 31, 2026
beyond-the-stigma-redefining-breast-cancer-as-a-universal-health-crisis
  • Survivorship and Post-Treatment

Beyond the Stigma: Redefining Breast Cancer as a Universal Health Crisis

Asro October 31, 2026
navigating-the-uncharted-lessons-from-the-breast-cancer-community
  • Survivorship and Post-Treatment

Navigating the Uncharted: Lessons from the Breast Cancer Community

Suro Senen October 30, 2026

Recent Posts

  • Landmark Discovery Unveils Epigenetic "Switch" Driving Colorectal Cancer Liver Metastasis
  • A Visionary at the Helm: Patrick J. Sinko Named Chief Science Officer of AAPS
  • The Genetic Blueprint of Resilience: Largest Twin Study Unlocks Why We Respond Differently to Life’s Challenges
  • The Genetic Frontier: How the Broad Institute is Reshaping Modern Medicine
  • Finding Stillness in the Season of Shift: 4 Grounding Yoga Poses for Autumn

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

landmark-discovery-unveils-epigenetic-switch-driving-colorectal-cancer-liver-metastasis
  • Medical Research and Clinical Trials

Landmark Discovery Unveils Epigenetic "Switch" Driving Colorectal Cancer Liver Metastasis

Nana Muazin October 31, 2026
a-visionary-at-the-helm-patrick-j-sinko-named-chief-science-officer-of-aaps
  • Treatment Innovations

A Visionary at the Helm: Patrick J. Sinko Named Chief Science Officer of AAPS

Asro October 31, 2026
Legs, toes, feet and heels of newborn twins. Wrapped in a knitted white blanket. Studio macro photography of the legs of newborn twins, close-up white backgraund. Two newborns.
  • Genomics and Precision Medicine

The Genetic Blueprint of Resilience: Largest Twin Study Unlocks Why We Respond Differently to Life’s Challenges

Laily UPN October 31, 2026
the-genetic-frontier-how-the-broad-institute-is-reshaping-modern-medicine
  • Genomics and Precision Medicine

The Genetic Frontier: How the Broad Institute is Reshaping Modern Medicine

Muslim October 31, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.